UA90654C2 - Полимерные конъюгаты интерферона-бета с повышенной биологической активностью - Google Patents
Полимерные конъюгаты интерферона-бета с повышенной биологической активностьюInfo
- Publication number
- UA90654C2 UA90654C2 UAA200507467A UA2005007467A UA90654C2 UA 90654 C2 UA90654 C2 UA 90654C2 UA A200507467 A UAA200507467 A UA A200507467A UA 2005007467 A UA2005007467 A UA 2005007467A UA 90654 C2 UA90654 C2 UA 90654C2
- Authority
- UA
- Ukraine
- Prior art keywords
- beta
- interferon
- biological potency
- polymer conjugates
- enhanced biological
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43602002P | 2002-12-26 | 2002-12-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
UA90654C2 true UA90654C2 (ru) | 2010-05-25 |
Family
ID=37134126
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200507467A UA90654C2 (ru) | 2002-12-26 | 2003-12-23 | Полимерные конъюгаты интерферона-бета с повышенной биологической активностью |
UAA200507468A UA91325C2 (ru) | 2002-12-26 | 2003-12-23 | Полимерные конъюгаты цитокинов, хемокинов, факторов роста, полипептидных гормонов и их антагонистов с сохраненной активностью рецепторного связывания |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200507468A UA91325C2 (ru) | 2002-12-26 | 2003-12-23 | Полимерные конъюгаты цитокинов, хемокинов, факторов роста, полипептидных гормонов и их антагонистов с сохраненной активностью рецепторного связывания |
Country Status (3)
Country | Link |
---|---|
CN (2) | CN1852732A (zh) |
UA (2) | UA90654C2 (zh) |
ZA (2) | ZA200505393B (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103965347B (zh) * | 2007-05-02 | 2017-07-18 | Ambrx公司 | 经修饰干扰素β多肽和其用途 |
KR101292740B1 (ko) * | 2008-08-25 | 2013-08-05 | 주식회사 바이오폴리메드 | 인터루킨-11 유사체를 포함하는 생체중합체 결합체 |
HUE054318T2 (hu) * | 2010-11-12 | 2021-08-30 | Nektar Therapeutics | IL-2 molekularész konjugátumai és polimer |
AR096890A1 (es) * | 2013-07-12 | 2016-02-03 | Hanmi Pharm Ind Co Ltd | Conjugando fc de inmunoglobulina, que mantiene la afinidad de unión del fragmento fc de la inmunoglobulina a fcrn |
MX2017000116A (es) * | 2014-06-30 | 2017-05-30 | Altor Bioscience Corp | Moleculas basadas en il-15 y metodos para su uso. |
CN104725482A (zh) * | 2015-04-06 | 2015-06-24 | 苏州普罗达生物科技有限公司 | 一种血小板衍生因子拮抗多肽及其应用 |
JP7280193B2 (ja) * | 2017-03-16 | 2023-05-23 | ブレイズ バイオサイエンス, インコーポレイテッド | 軟骨ホーミングペプチドコンジュゲート及びその使用方法 |
MX2020012252A (es) * | 2018-05-14 | 2021-04-28 | Werewolf Therapeutics Inc | Polipeptidos de interleucina 12 activables y metodos de uso de los mismos. |
CN113797318B (zh) * | 2021-10-26 | 2023-06-30 | 深圳科兴药业有限公司 | 一种干扰素组合物及其制备方法和应用 |
CN117711525B (zh) * | 2024-02-05 | 2024-05-10 | 北京悦康科创医药科技股份有限公司 | 活性预测模型训练及活性预测相关产品 |
-
2003
- 2003-12-23 ZA ZA200505393A patent/ZA200505393B/en unknown
- 2003-12-23 UA UAA200507467A patent/UA90654C2/ru unknown
- 2003-12-23 CN CNA2003801090344A patent/CN1852732A/zh active Pending
- 2003-12-23 UA UAA200507468A patent/UA91325C2/ru unknown
- 2003-12-23 ZA ZA200505394A patent/ZA200505394B/en unknown
- 2003-12-23 CN CN 200380109611 patent/CN1859925A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
ZA200505393B (en) | 2007-03-28 |
CN1852732A (zh) | 2006-10-25 |
ZA200505394B (en) | 2007-03-28 |
UA91325C2 (ru) | 2010-07-26 |
CN1859925A (zh) | 2006-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200631594A (en) | Toll like receptor 3 antagonists, methods and uses | |
EP1462459A4 (en) | PROCESS FOR PRODUCING MODIFIED POLYMER, MODIFIED POLYMER OBTAINED BY THIS PROCESS, AND RUBBER COMPOSITION | |
IL186265A0 (en) | Il-21 variants | |
BRPI0519047A2 (pt) | mÉtodo para a produÇço de um agente de contraste marcador ou agente terapÊutico marcador, agentes de contraste marcadores e uso de agentes de contraste marcadores ou de agentes terapÊuticos marcadores | |
AU2002366083A8 (en) | Matrix for the production of tissue engineered ligaments, tendons and other tissue | |
WO2001026693A3 (en) | Manufacture of polyglutamate-therapeutic agent conjugates | |
WO2003104425A3 (en) | NEW STABLE ANTI-CD22 ANTIBODIES | |
UA90654C2 (ru) | Полимерные конъюгаты интерферона-бета с повышенной биологической активностью | |
ZA200208489B (en) | Salt-sensitive, water-dispersible polymer composition. | |
AU8727201A (en) | Genes involved in intestinal inflammatory diseases and use thereof | |
HRP20070291T3 (en) | Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis | |
DE60113445D1 (de) | Substanzen mit verzweigten linkermolekülen | |
CY1105317T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων | |
CY1105142T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων | |
MY149864A (en) | Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties | |
WO2003106655A3 (en) | FIBROUS IMMOBILIZATION SYSTEMS OF PROTEINS | |
ITTO20000674A0 (it) | Composizioni a base di aminoacidi, atte al trattamento dell'insufficienza cardiaca. | |
AU5909600A (en) | 17867, a novel human aminopeptidase | |
MXPA02012259A (es) | Polimeros que estan modificados por medio de grupos funcionales. | |
WO2001036605A3 (en) | 2786, a human aminopeptidase | |
WO2005032491A3 (en) | Methods and compositions for mycoplasma pneumoniae exotoxins | |
MXPA05009428A (es) | Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas. | |
AU2002254930A1 (en) | Novel medicament compositions based on anticholinergic agents and endothelin antagonists | |
DE60125360D1 (de) | Abfrageprüfgerät, das Überabtastung zur Synchronisierung verwendet | |
FR2845916B1 (fr) | Composition pharmaceutique associant le tenatoprazole et un antagoniste des recepteurs h2 a l'histamine |